Announcements Trials
Browse Landscape

Status

Recruiting 2Completed 2Active not recruiting 2

Sponsor Class

INDUSTRY 5OTHER 1

Study Type

Interventional 67Observational 6

Sponsor

Cancer Type

Breast 6

Conditions

Breast Neoplasms 6

Interventions

Surveys and Questionnaires 53Blood Specimen Collection 53Specimen Handling 28Radiotherapy 18Observation 18Interviews as Topic 13Magnetic Resonance Spectroscopy 12Surgical Procedures, Operative 10Drug Therapy 10Data Collection 10Biopsy 10Tomography, X-Ray Computed 9darolutamide 8Watchful Waiting 7Standard of Care 7ribociclib 6palbociclib 6Restraint, Physical 6Patient Reported Outcome Measures 6Magnetic Resonance Imaging 6Immune Checkpoint Inhibitors 6trastuzumab deruxtecan 5Positron-Emission Tomography 5Mass Screening 5Genetic Testing 5Esophagectomy 5Breath Tests 5Bevacizumab 5enzalutamide 4apalutamide 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Observational × palbociclib × 90 days × Clear all
NCT07347600 2026-05-18

reaINAVO

Hoffmann-La Roche

Recruiting
500 enrolled
Breast

Breast Neoplasms

NCT04767594 2026-04-13

PERFORM

Pfizer

Active not recruiting
1,407 enrolled
Breast

Breast Neoplasms

NCT05399329 2026-04-09

Study to Evaluate Real-world Effectiveness With Palbociclib Plus Endocrine Therapy as First-line/Second-line Treatment for HR+/HER2- Advanced Breast Cancer in Japan

Pfizer

Completed
693 enrolled
Breast

Breast Neoplasms

NCT06962969 2026-04-02

A Study to Understand the Patients Confirmed to Have Advanced or Metastatic Breast Cancer and Receiving Palbociclib Treatment Using a Real-world Database

Pfizer

Completed
1 enrolled
Breast

Breast Neoplasms

NCT04654208 2026-03-31

SIRI

Pfizer

Recruiting
1,500 enrolled
Breast

Breast Neoplasms

NCT07493291 2026-03-30

PALLAS-IRAQ

Al-Mustansiriyah University

Active not recruiting
100 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡